共 26 条
[1]
BENJAMIN RS, 1977, CANCER RES, V37, P1416
[2]
CAMAGGI CM, 1985, DRUG EXP CLIN RES, V11, P285
[3]
CHLEBOWSKI RT, 1981, CANCER, V48, P1088, DOI 10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO
[4]
2-W
[5]
DISPOSITION KINETICS OF ADRIAMYCIN, ADRIAMYCINOL AND THEIR 7-DEOXYAGLYCONES IN AKR MICE BEARING A SUB-CUTANEOUSLY GROWING RIDGWAY OSTEOGENIC-SARCOMA (ROS)
[J].
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY,
1986, 22 (04)
:451-460
[6]
MEASUREMENT OF THE S-ALPHA-T SEGMENT AS THE MOST RELIABLE ELECTROCARDIOGRAM PARAMETER FOR THE ASSESSMENT OF ADRIAMYCIN-INDUCED CARDIOTOXICITY IN THE RAT
[J].
JOURNAL OF PHARMACOLOGICAL METHODS,
1986, 16 (03)
:251-259
[7]
EXOGENOUS DOXORUBICINOL INDUCES CARDIOTOXIC EFFECTS IN RATS
[J].
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY,
1987, 23 (07)
:907-913
[8]
DELTACCA M, 1980, HISTOCHEMISTRY, V65, P187, DOI 10.1007/BF00493168
[9]
MIGHT ADRIAMYCINOL CONTRIBUTE TO ADRIAMYCIN-INDUCED CARDIOTOXICITY
[J].
PHARMACOLOGICAL RESEARCH COMMUNICATIONS,
1985, 17 (11)
:1073-1084
[10]
DOROSHOW JH, 1983, CANCER RES, V43, P460